January 20, 2025 - 18:15

Philippines Finance Secretary Ralph Recto recently shared his insights on the country's economic landscape during an interview at the World Economic Forum's annual meeting in Davos, Switzerland. In a discussion with Haslinda Amin, Recto addressed several pressing issues, including the impact of tariffs and inflation on the nation's economy.
As the global economic climate shifts, Recto emphasized the importance of adapting to new challenges, particularly in light of the recent changes in U.S. leadership. He noted that the Philippines must navigate these developments carefully to sustain its economic growth and stability.
Additionally, Recto touched on the topic of cryptocurrency, highlighting its growing relevance in the Philippines. He underscored the need for regulatory frameworks to ensure the safe and responsible use of digital currencies, which could offer new opportunities for innovation and financial inclusion in the country. His remarks reflect a proactive approach to addressing both traditional economic issues and the emerging trends in the financial sector.
May 9, 2026 - 22:04
Compass Diversified Q1 Earnings Call HighlightsCompass Diversified, the publicly traded holding company known as CODI, reported its first-quarter 2026 earnings this week, with management framing the period as one of disciplined execution. Chief...
May 9, 2026 - 00:34
Urbana Corporation Has Filed 2026 First Quarter Interim Financial StatementsTORONTO - Urbana Corporation has submitted its unaudited interim financial statements and management discussion for the first quarter of 2026. The filing covers the three-month period ending March...
May 8, 2026 - 11:59
Australia regulator calls for urgent cybersecurity action to counter MythosAustralia`s corporate watchdog has called on the country`s financial industry to take urgent steps to address cybersecurity risks posed by advanced artificial intelligence systems, including a...
May 7, 2026 - 20:22
IN8bio Reports First Quarter 2026 Financial Results and Recent Business HighlightsIN8bio, a clinical-stage biopharmaceutical company focused on gamma-delta T cell therapies, announced its financial results for the first quarter of 2026 along with key business updates. The...